Vera Therapeutics, Inc. (VERA) Stock Analysis — Probabli.AI
AI-powered analysis for VERA (Vera Therapeutics, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $34.95 · Market cap: $2.6B · AI outlook: Bullish
Vera Therapeutics presents a compelling bullish investment opportunity due to its strong pipeline, recent positive developments, and substantial analyst backing with high price targets. Despite some challenges such as ongoing patent disputes and negative EPS surprise history, strategic moves like FDA fast track designation and international expansion significantly bolster its growth potential.…
Probabilistic 1-Year Outlook
- Bull 55% · Neutral 30% · Bear 15%
- 1-year price estimates — P10: $29 / P50: $49 / P90: $83
- Vera Therapeutics has several bullish signals: a strong analyst consensus with a median target implying significant upside (+123.5%), recent positive headlines including FDA fast track designation and key partnerships,…
5-Year Outlook
- Bull 65% · Neutral 25% · Bear 10%
- 5-year price estimates — P10: $40 / P50: $93 / P90: $149
SWOT Highlights
- Strength: Strong analyst consensus with significant upside targets
- Strength: Recent FDA fast track designation for lead candidate
- Risk: Negative average EPS surprise
- Risk: Ongoing patent dispute
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
14 Wall Street analysts rate VERA a STRONG BUY with a mean price target of $78.
Last analyzed · Model: gpt-4o. How this forecast works · Accuracy & validation.
VERA forecast details · VERA sentiment details · VERA insider activity
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.